Endocrine treatment of prostate cancer

This publication has 67 references indexed in Scilit:

• The clinical implications of the difference between castration, gonadotrophin releasing‐hormone (GnRH) antagonists and agonist treatment on the morphology and expression of GnRH receptors in the rat ventral prostate
  BJU International, 2003
• A Randomised Comparison of Bicalutamide ('Casodex') 150 mg versus Placebo as Immediate Therapy Either Alone or as Adjuvant to Standard Care for Early Non-Metastatic Prostate Cancer First Report from the Scandinavian Prostatic Cancer Group Study No. 6
  European Urology, 2002
• PROSPECTIVE EVALUATION OF HOT FLASHES DURING TREATMENT WITH PARENTERAL ESTROGEN OR COMPLETE ANDROGEN ABLATION FOR METASTATIC CARCINOMA OF THE PROSTATE
  Journal of Urology, 2001
• Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate Cancer
  New England Journal of Medicine, 1999
• Parenteral polyoestradiol phosphate vs orchidectomy in the treatment of advanced prostatic cancer. Efficacy and cardiovascular complications: a 2‐year follow‐up report of a national, prospective prostatic cancer study
  British Journal of Urology, 1998
• Non-steroidal anti-androgen monotherapy of advanced prostate cancer ??? A reasonable option
  Current Opinion in Urology, 1997
• Osteoporosis After Orchiectomy for Prostate Cancer
  Journal of Urology, 1997
• The position of cyproterone acetate (CPA), a steroidal anti-androgen, in the treatment of prostate cancer
  The Prostate, 1992
• Quantal relationship between prostatic dihydrotestosterone and prostatic cell content: Critical threshold concept
  The Prostate, 1987
• The Effects of Orchidectomy, Estrogens, and Cyproterone Acetate on Plasma Testosterone, LH, and FSH Concentrations in Patients with Carcinoma of the Prostate
  Scandinavian Journal of Urology and Nephrology, 1982